We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Expandable Interbody Implant Restores Lumbar Lordosis

By HospiMedica International staff writers
Posted on 14 Sep 2021
Print article
Image: The IO expandable lumbar interbody (Photo courtesy of MiRus)
Image: The IO expandable lumbar interbody (Photo courtesy of MiRus)
A new superalloy implant treats lordosis in adults with degenerative disc disease (DDD) at one or two contiguous levels, from L1-L2 to L5-S1.

The MiRus (Atlanta, GA, USA) IO Expandable Lumbar Interbody features a low insertion profile (4mm), a high expansion profile (18mm), and wide lordosis angle (24◦). Powered by the MoRe expansion engine, it is designed to minimize insertion height and maximize expansion height, thus making it easier for surgeons to restore lordosis and maintain sagittal balance, while reducing the challenges of insertion and related neural injury. The IO can be used in both posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) procedures.

The high strength of the MoRe superalloy allows implant designers to significantly reduce overall dimensions, so that they are thinner and less prominent. The higher ductility also results in more tolerance to deformation and reduced crack formation, increasing implant life. In addition, MoRe is highly biocompatible and osteoconductive, thus reducing allergic reactions and biofilm formation. The IO expandable implant allows for 2.5cc of biologic material to be post-packed into the inter-vertebral space.

“IO continues the MiRus philosophy of using the MoRe superalloy to create implants that objectively exceed the specifications of the existing market leading products; this delivers immense value to surgeons and patient care,” said Mahesh Krishnan, chief commercial officer of MiRus. “The IO expandable lumbar interbody will meet the significant demand of our surgeons and distribution channels, who have long anticipated a lower profile and best-in-class expandable interbody.”

MoRe is a highly pure alloy containing only two elements: Molybdenum (Mo; 52.5%) and Rhenium (Re; 47.5%). It has an extremely high density (13.52 gm/cm3) and modulus of elasticity (365 GPa), as compared to contemporary titanium-base, cobalt-base, and stainless steel implant materials. In addition, the superalloy has a lower magnetic susceptibility than commercially pure titanium, which translates into a reduced amount of magnetic resonance imaging (MRI) artifacts.

Related Links:
MiRus

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.